Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Centers for Disease Control and Prevention
Susan E Dorman; Payam Nahid; Ekaterina V Kurbatova; Patrick P J Phillips; Kia Bryant; Kelly E Dooley; Melissa Engle; Stefan V Goldberg; Ha T T Phan; James Hakim; John L Johnson; Madeleine Lourens; Neil A Martinson; Grace Muzanyi; Kim Narunsky; Sandy Nerette; Nhung V Nguyen; Thuong H Pham; Samuel Pierre; Anne E Purfield; Wadzanai Samaneka; Radojka M Savic; Ian Sanne; Nigel A Scott; Justin Shenje; Erin Sizemore; Andrew Vernon; Ziyaad Waja; Marc Weiner; Susan Swindells; Richard E Chaisson; AIDS Clinical Trials Group; Tuberculosis Trials Consortium